# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA3832793 | Functional | AntiCryptosporidium parvum activity Compounds added 3h after t0, IC 50 (uM) | Cryptosporidium parvum | 9 | ALA3832761 | organism-based format | MMV Pathogen Box | |
2. | ALA3832794 | Functional | AntiCryptosporidium parvum activity Compounds added at t0, IC 50 (uM) | Cryptosporidium parvum | 10 | ALA3832761 | organism-based format | MMV Pathogen Box | |
3. | ALA660450 | Functional | percentage of controls is reported as the counted oocysts obtained from alimentary tract tissues using a blinded protocol on Cryptosporidium parvum at dose of 36.9 umol/kg/day | Cryptosporidium parvum | 1 | ALA1129395 | organism-based format | Scientific Literature | |
4. | ALA660451 | Functional | percentage of controls is reported as the counted oocysts obtained from alimentary tract tissues using a blinded protocol on Cryptosporidium parvum at dose of 37.9 umol/kg/day | Cryptosporidium parvum | 1 | ALA1129395 | organism-based format | Scientific Literature | |
5. | ALA660452 | Functional | percentage of controls is reported as the counted oocysts obtained from alimentary tract tissues using a blinded protocol on Cryptosporidium parvum at dose of 62 umol/kg/day | Cryptosporidium parvum | 1 | ALA1129395 | organism-based format | Scientific Literature | |
6. | ALA661281 | Functional | percentage of controls is reported as the counted oocysts obtained from alimentary tract tissues using a blinded protocol on Cryptosporidium parvum at dose of 72.2 umol/kg/day | Cryptosporidium parvum | 1 | ALA1129395 | organism-based format | Scientific Literature | |
7. | ALA867063 | Functional | Antiparasitic activity against Cryptosporidium parvum in HCT8 cells | Cryptosporidium parvum | 15 | ALA1149465 | organism-based format | Scientific Literature | |
8. | ALA918870 | Functional | Prevention of Cryptosporidium parvum infection in TCR alpha deficient-mouse pretreated with 20 mg/kgday, po for 2 days prior to oocyst infection and continued for 5 days | Cryptosporidium parvum | 1 | ALA1147096 | organism-based format | Scientific Literature | |
9. | ALA918871 | Functional | Prevention of Cryptosporidium parvum infection in TCR alpha deficient-mouse pretreated with 50 mg/kg/day, po for 2 days prior to oocyst infection and continued for 5 days | Cryptosporidium parvum | 1 | ALA1147096 | organism-based format | Scientific Literature | |
10. | ALA918872 | Functional | Anticryptosporidial activity against Cryptosporidium parvum infected TCR alpha deficient-mouse assessed as prevention of oocyst shedding at 20 mg/kg/day after 7 days | Cryptosporidium parvum | 2 | ALA1147096 | organism-based format | Scientific Literature | |
11. | ALA918873 | Functional | Anticryptosporidial activity against Cryptosporidium parvum infected TCR alpha deficient-mouse assessed as prevention of oocyst shedding at 16 mg/kg twice a day after 7 days | Cryptosporidium parvum | 1 | ALA1147096 | organism-based format | Scientific Literature | |
12. | ALA918874 | Functional | Anticryptosporidial activity against Cryptosporidium parvum infected TCR alpha deficient-mouse assessed as prevention of oocyst shedding at 134 mg/kg/day after 7 days | Cryptosporidium parvum | 2 | ALA1147096 | organism-based format | Scientific Literature | |
13. | ALA917857 | Functional | Effect on infection of HCT8 cells by Cryptosporidium parvum oocytes isolated from mouse treated with 134 mg/kg/day for 7 days assessed as viability of recoverd oocytes | Cryptosporidium parvum | 1 | ALA1147096 | organism-based format | Scientific Literature | |
14. | ALA896611 | Functional | Antiprotozoal activity against Cryptosporidium parvum at 0.8 nM | Cryptosporidium parvum | 3 | ALA1149546 | organism-based format | Scientific Literature | |
15. | ALA896612 | Functional | Antiprotozoal activity against Cryptosporidium parvum up to 6 nM | Cryptosporidium parvum | 2 | ALA1149546 | organism-based format | Scientific Literature | |
16. | ALA896610 | Functional | Antiprotozoal activity against Cryptosporidium parvum | Cryptosporidium parvum | 3 | ALA1149546 | organism-based format | Scientific Literature | |
17. | ALA1217012 | Functional | Antimicrobial activity against Cryptosporidium parvum | Cryptosporidium parvum | 258 | ALA1212812 | organism-based format | Scientific Literature | |
18. | ALA1246871 | Functional | Antiparasitic activity against Cryptosporidium parvum infected in human HTC8 cells after 46 hrs by immunofluorescence method | Cryptosporidium parvum | 40 | ALA1240395 | organism-based format | Scientific Literature | |
19. | ALA1264854 | Functional | Antiparasitic activity against Cryptosporidium parvum infected in human HCT-8 cells assessed as growth inhibition at 2 mg/ml after 48 hrs | Cryptosporidium parvum | 1 | ALA1255256 | organism-based format | Scientific Literature | |
20. | ALA1264855 | Functional | Antimicrobial activity against Cryptosporidium parvum infected in HCT8 cells assessed as growth inhibition at 90 uM pretreated for 30 min before infection measured after 48 hrs | Cryptosporidium parvum | 1 | ALA1255256 | organism-based format | Scientific Literature |